Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 10:20 a.m.

    📋 AMNEAL PHARMACEUTICALS, INC. (AMRX) - Financial Results

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 06:19:05

    Event Type: Financial Results

    Event Details:

    Amneal Pharmaceuticals Inc. (AMRX) Reports Q4 2025 Financial Results Amneal Pharmaceuticals Inc. (AMRX) announced its financial results for the period ending Q4 2025. Key Financial Highlights:
    • Revenue: 533987
    • Net Income: 54402
    • EPS: 0.17
    • Cash and equivalents: 201249

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Selling General Administrative 46.01K -8.10K $54.11K +668.06%
    Other Expense Income Interest Expense -65.51K -184.85K $119.34K +64.56%
    Other Expense Income Other Income Net 1.18K 3.36K $-2.18K -64.91%
    Current Assets Prepaid Expenses Other Current Assets 101.51K 80.72K $20.79K +25.76%
    Current Assets Property Equipment Net 434.99K 424.91K $10.08K +2.37%
    Current Assets Intangible Assets Net 587.94K 732.38K $-144.44K -19.72%
    Current Assets Operating Lease Right Of Use Assets 31.77K 31.39K $381.00 +1.21%
    Current Assets Other Assets 39.46K 60.13K $-20.68K -34.38%
    Current Liabilities Operating Lease Liabilities 26.41K 24.81K $1.59K +6.41%
    Current Liabilities Other Long Term Liabilities 2.78M 2.42M $363.73K +15.05%
    Adjusted To Add Interest Expense 65.51K 196.93K $-131.42K -66.73%
    Revenue 784.51K 784.51K $0.00 +0.00%
    Selling, General & Administrative 137.81K 118.69K $19.12K +16.11%
    Interest Expense -62.81K -65.51K $2.70K +4.12%
    Other Income, Net 1.24K 1.18K $57.00 +4.84%
    Noncontrolling Interests -15.76K -11.91K $-3.85K -32.32%
    Prepaid Expenses and Other Current Assets 101.51K 80.72K $20.79K +25.76%
    Intangible Assets, Net 587.94K 732.38K $-144.44K -19.72%
    Other Assets 39.46K 60.13K $-20.68K -34.38%
    Accounts Payable 731.83K 731.83K $0.00 +0.00%
    Operating Lease Liabilities 7.99K 9.44K $-1.45K -15.37%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Amneal Pharmaceuticals Inc.
    • CIK: 0001723128
    • Ticker Symbol: AMRX
    • Period End Date: 2025-10-30
    • Document Type: 8-K

Search

News categories